Share This Page:   

 

Browse by Clinical Topic:
Select a Topic to Learn More

Featured CME/CE Content:

 

neuroscienceCME Editors' Picks:

Health Inequities in Joint Health Care

Premiere Date: Thursday, October 13, 2022

This activity offers CE credit for:

1. ABIM (MOC)
2. ABA (MOC)
3. Medicine (accme)
4. Nursing (ANCC)
5. Pharmacy (acpe)
6. PA (aapa)
7. Dietetic Registration (CDR)
8. Other

All other clinicians will receive a Certificate of Attendance stating this activity was certified for AMA PRA Category 1 Credit™

Credit Expiration Date:
Monday, October 13, 2025

Faculty

Monica E. Peek, MD, MPH, MSc (Moderator) (she/her/hers) Ellen H. Block Professor of Health Justice in the Department of Medicine Associate Director, Chicago Center for Diabetes Translation Research Director of Research, MacLean Center for Clinical Medical Ethics The University of Chicago Chicago, IL

Antonia F. Chen, MD, MBA  Director of Research, Arthroplasty Services Associate Professor of Orthopaedic Surgery Harvard Medical School Boston, MA

Statement of Need

Proper therapeutic and surgical interventions in conjunction with adequate pain management play crucial roles in determining the quality of life (QoL) of patients with joint health care needs. Patients in racial and ethnic underserved communities endure the systemic effects of unconscious biases and historical and structural racism and as such, health care providers (HCPs) need to be cognizant of their interactions with patients when assessing joint health and joint arthroplasty. Education, chronic disease, economic stability, social support systems, and environmental factors all play into a patient’s individual needs in the context of joint health care, and providers must consider all these factors when engaging with the patient and developing holistic treatment goals in partnership with patients. It is critical that providers do a thorough history to understand how a patient’s occupation, burden of chronic diseases, and lack of social support may impact joint health and post-surgical outcomes.

In this podcast installment of a diversity, equity, and inclusion (DEI) series, Drs. Peek and Chen will discuss strategies vital to combating biases and inequities in joint health care. This engaging discussion will discuss modern day issues that need addressed to ensure equitable health care and the faculty will provide real-world action steps to improve joint health care for all patients.

Learning Objectives

At the end of this CE activity, participants should be able to:

• Analyze the influence of unconscious bias, health disparities, and health inequities on joint health care.

Financial Support

Supported by an educational grant from Johnson & Johnson.

Target Audience

Physicians, PAs, NPs, nurses, and pharmacists specializing in rheumatology, orthopedics, surgery, pain, anesthesiology, or primary care.

Credit Information

ABIM MOC:
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 0.5 medical knowledge MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Learning formats: Enduring material

Royal College MOC
Through an agreement between the Accreditation Council for Continuing Medical Education and the Royal College of Physicians and Surgeons of Canada, medical practitioners participating in the Royal College MOC Program may record completion of accredited activities registered under the ACCME’s “CME in Support of MOC” program in Section 3 of the Royal College’s MOC Program.

MIPS Improvement Activity:
This activity counts towards MIPS Improvement Activity requirements under the Medicare Access and CHIP Reauthorization Act of 2015 (MACRA). Clinicians should submit their improvement activities by attestation via the CMS Quality Payment Program website.

It is the policy of CME Outfitters, LLC, to ensure independence, balance, objectivity, and scientific rigor and integrity in all of their CE activities. Faculty must disclose to the participants any relationships with commercial companies whose products or devices may be mentioned in faculty presentations, or with the commercial supporter of this CE activity. CME Outfitters, LLC, has evaluated, identified, and mitigated any potential conflicts of interest through a rigorous content validation procedure, use of evidence-based data/research, and a multidisciplinary peer review process. The following information is for participant information only. It is not assumed that these relationships will have a negative impact on the presentations.

Dr. Peek reports the following financial relationships:

Consultant: Pfizer Inc.

Dr. Chen reports the following financial relationships:

Advisory Board: Irrimax Corporation

Consultant: Adaptive Phage Therapeutics; Avanos Medical, Inc.; Best In Class MD (BICMD); Convatec; Ethicon, Inc.; GLG. Pharma, Inc.; Guidepoint Global, LLC; Heraeus Medical USA; Irrimax Corporation; and Pfizer Inc.

Research Support: Nutrimedy Inc.

Stock Shareholder (ownership interest): Hyalex Orthopaedics, Inc.; IlluminOss Medical, Inc.; Irrimax Corporation; Joint Purification Systems (JPS); and Sonoran Biosciences, Inc.

Other Financial or Material Support: Royalties: SLACK Incorporated; Stryker; and UpToDate, Inc.

The following peer reviewer and CME Outfitters staff have no financial relationships:

Jeffrey Helfand, DO (peer reviewer)

Meghann Taft-Lockard (planning committee)

Susan Perry (planning committee)

Kasey Brandt, PharmD (planning committee)

Sandra Caballero, PharmD (planning committee)

Susan H. Yarbrough, CHCP (planning committee)

Sharon Tordoff (planning committee)

Faculty of this CE activity may include discussions of products or devices that are not currently labeled for use by the FDA. The faculty have been informed of their responsibility to disclose to the audience if they will be discussing off-label or investigational uses (any uses not approved by the FDA) of products or devices.

Questions about this activity? Call us at 877.CME.PROS (877.263.7767).